Cargando…
The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
Autores principales: | Liang, Weifeng, Gu, Ming, Zhu, Lingxiang, Yan, Ziqi, Schenten, Dominik, Herrick, Shelby, Li, Hongmin, Samrat, Subodh Kumar, Zhu, Jiapeng, Chen, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098221/ https://www.ncbi.nlm.nih.gov/pubmed/37055405 http://dx.doi.org/10.1038/s41392-023-01418-3 |
Ejemplares similares
-
Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022) -
Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
por: Samrat, Subodh K., et al.
Publicado: (2022) -
Quaternary Structure of the SARS Coronavirus Main Protease
por: Chang, Gu-Gang
Publicado: (2009) -
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
por: Samrat, Subodh Kumar, et al.
Publicado: (2020) -
Repression of CC16 by Cigarette Smoke (CS) Exposure
por: Zhu, Lingxiang, et al.
Publicado: (2015)